Kids sunscreen recalled over 'impurities' found in bottles. Here's how to check yours
Sold at national retailers, the company issued a voluntary recall on the Babyganics Kids SPF 50+ Mineral Sunscreen continuous spray and rollerball varieties, both in the Totally Tropical scent. The company says that no other products are affected by the recall.
Because Babyganics' specific lots failed to meet "quality standards," the company says that customers can return the affected product for a full refund. In 2022, the brand recalled its bubble bath, due to the presence of the bacterium Pluralibacter gergoviae according to the Food and Drug Administration.
Why you need to wear sunscreen in the summer
According to PR Newswire, the recalled sunscreen is not a risk to health or safety, but failed to meet the quality threshold. Customers can return or discard the affected SKUs by visiting the Babyganics website to determine if the products they bought are affected.
There are two products affected, according to the company:
Babyganics kids SPF 50+ mineral sunscreen rollerball, totally tropical
Babyganics kids SPF 50+ mineral sunscreen continuous spray, totally tropical
Major retailers that sell Babyganics products include Target, Walmart, CVS and Walgreens, as well as online retailers like Amazon and Buy Buy Baby.
If you believe you bought any recalled Babyganics items, you can visit the company's recall website for more information. The company says customers can return the recalled sunscreen for a full refund.
This article originally appeared on The Columbus Dispatch: Kid's sunscreen brand recalled over potential impurities in bottles
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
11 hours ago
- Newsweek
Laura Loomer Blasts Return of FDA Vaccine Chief She Helped Force Out
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Laura Loomer has reacted with anger after a Food and Drug Administration (FDA) vaccine chief she criticized returned to the agency. Writing on X, formerly Twitter, the conservative commentator slammed President Donald Trump's administration for rehiring Dr. Vinay Prasad two weeks after he resigned from his role leading the FDA's vaccines and gene therapy division. Why It Matters Loomer is an influential figure in right-wing circles. She was present alongside Trump on the 2024 campaign trail, and she has been tied to his decision to fire National Security Adviser Mike Waltz and other aides, although the president has denied that she was the reason for the sackings. Prasad used to work for the University of California, San Francisco. He has also previously worked at the National Cancer Institute and the National Institutes of Health. Laura Loomer outside the U.S. Capitol on June 12, 2025, in Washington, D.C. Laura Loomer outside the U.S. Capitol on June 12, 2025, in Washington, D.C. Tom Williams/CQ Roll Call via AP Images What To Know Prasad, a physician who was first appointed to the role in May, left the FDA on July 30 following pressure from Loomer and other political influencers. Prasad had faced backlash over the agency's handling of a gene therapy linked to the deaths of two teenagers and his decision not to approve certain drugs. Loomer had also repeatedly claimed Prasad was liberal and said he was anti-Trump. "How did this Trump-hating Bernie [Sanders] Bro get into the Trump admin???" Loomer posted on X in July. Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary had defended Prasad, who was a critic of vaccine and mask mandates, prior to his resignation. After it was reported he would return, writing on X, Loomer called the decision to rehire Prasad "egregious." She also indicated she would launch critiques of other figures, saying she "will be ramping up my exposés of officials within the HHS [Department of Health and Human Services] and FDA so the American people can see more of the pay for play rot themselves and how rabid Trump haters continue to be hired in the Trump administration." NEW: In another egregious personnel decision under the Trump administration, it is now being reported that longtime progressive Marxist Vinay Prasad who referred to President Trump's supporters as criminals and compared them to drug addicts after saying he stabbed a Trump voodoo… — Laura Loomer (@LauraLoomer) August 9, 2025 What People Are Saying Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters: "At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research." When he resigned, Prasad said he "did not want to be a distraction to the great work of the FDA" and had "decided to return to California and spend more time with his family." What Happens Next As Trump's presidency continues, it is likely that there will be further personnel changes in government departments.
New York Post
a day ago
- New York Post
FDA pulls popular ice cream from shelves after packaging mix up: ‘Serious allergic reaction'
Ice cream lovers may have more than a meltdown. Friendly's Ice Cream has recalled one of its most popular flavors after a packaging mix up sparking an allergy risk warning from the Food and Drug Administration, which who said it could cause 'a serious or life-threatening allergic reaction.' DFA Dairy Brands, LLC, voluntarily pulled 324 cartons of its 48-fluid-ounce Friendly's Cookies & Cream ice cream from stores after they were packaged in Vanilla Bean containers but topped with Cookies & Cream lids, the FDA said. 3 Friendly's Ice Cream their Cookies & Cream ice cream from stores across the nation. Paul Weaver/SOPA Images / Shutterstock The Vanilla Bean flavor does not contain soy or wheat, which are present in Cookies & Cream. Therefore, the Vanilla Bean cartons don't list those ingredients, according to the FDA. 'For many people, a reaction to soy or wheat usually means abdominal pain, but you could get a rash, or less commonly, asthma-like symptoms,' said Dr. Joseph Raduazzo, an internal medicine specialist in Massachusetts. 3 Federal officials are warning that the mislabeling could have deadly consequences for allergy sufferers. friendlys 'For people with a severe allergy to soy or wheat, the reaction could be life-threatening, similar to when people with peanut allergies come into contact with the nut.' No illnesses or adverse reactions have been reported due to the mispackaging, according to the FDA website. The recalled ice cream was distributed through a single distribution center, UNFI, to retail stores in Maryland, Virginia and Pennsylvania, the agency said. 3 The recall was issued due to the Food and Drug Administration saying in what was a package mix-up that the 324 cartons of ice cream posed an allergy risk that can cause 'a serious or life-threatening allergic reaction.' REUTERS No other Friendly's products were included, a recorded message on a Friendly's consumer hotline said. Last month, Florida-based Rich's Ice Cream recalled over 100,000 ice cream bars in 23 states – including New York and Pennsylvania – due to listeria concerns. The voluntary removal from the market was one of the largest ice cream recalls in recent history.
The Hill
2 days ago
- The Hill
FDA says IV saline shortage is over
A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday. According to the FDA, sodium chloride 0.9% injection products have been in shortage since 2018. The shortage was exacerbated when Hurricane Helene flooded a Baxter manufacturing plant in Marion, N.C. last fall what was responsible for 60 percent of the IV fluid in the country. 'This marks a significant milestone for public health and reinforces the FDA's commitment to ensuring Americans have consistent access to life-saving medical products,' FDA Commissioner Marty Makary said in a statement. Hospitals were left scrambling in the aftermath of Helene, as the shortage of multiple types IV fluid highlighted the fragility and vulnerability of the country's medical supply chain. Many were forced to curtail elective procedures and ration supplies. The IV fluid market is made up of primarily four manufacturers: Baxter International, which makes about 60 percent; B. Braun Medical, which makes about 23 percent; along with ICU Medical and Fresenius Kabi. It's common to see the same products go on and off the shortage list for years. Prior to Helene, certain IV solutions had been in shortage for almost 10 years. Experts have long warned about allowing critical supplies to be highly concentrated in one place. But manufacturing requirements for sterility mean a high barrier to entry into the market, and with low returns on investment for manufacturers, hospitals and suppliers have few options for recourse. The FDA said it is working closely with manufacturers and will continue to monitor the supply of other IV fluids, which are still in shortage. 'The availability of reliable medical products is essential to patient care and the overall resilience of our healthcare system. Addressing this shortage has been a top priority for the FDA,' Makary said.
